William A. Riley headshot
William A. Riley, Senior Director, Health Systems Solutions & Decision Science, AllianceRx Walgreens Pharmacy

340B INDUSTRY LEADER SPOTLIGHT

William A. Riley, Senior Director, Health Systems Solutions & Decision Science, AllianceRx Walgreens Pharmacy

William A. Riley

Q: Where did you grow up?

I had the honor to grow up with both of my parents serving in the Air Force so we did move around a fair amount in my younger years. However, I spent the majority of my childhood in Tuscola, IL, just 30 minutes from Champaign, home of University of Illinois.

Q: Where did you go to college/graduate school?

I have a BS from Eastern Illinois University and I am a 2022 candidate for Harvard’s Executive Business Analytics Program.

Q: What are your favorites?

Food: Mediterranean

Movie: The filmed version of the Broadway original “Hamilton”

Musicians: Sam Cooke & Tyler Childers

Destination: Tuvalu

Q: What do you like to do outside of work?

I spend most of my time outside of work giving back to the community that provides myself and my family a great place to call home. I volunteer as a Plan and Zoning Commissioner for the Village of Lake Zurich, as a Ballot Box Judge for the Lake County Board of Elections, Chancellor of Knights of Columbus and a head coach for my children’s various sporting activities.

I also volunteer professionally as a GWU School of Business Advisory Council Member & University of South Florida’s Muma College of Business, Executive Programs Advisory Council member.

Q: What kind of work does your company do in 340B and what makes it stand out?

AllianceRx Walgreens Pharmacy is a Specialty Pharmacy that acts as a 340B administrator, a contract pharmacy and a crucial source of Limited Distribution Drugs (LDD).

With the most access to LDDs with more than 200 specialty medications available as well as partnerships with a broad array of networks, AllianceRx Walgreens Pharmacy is a leader in servicing patients with the most complex advanced therapies.

Q: Why did you choose to work in the 340B space?

The reason I choose to work in the 340B industry 15 years ago and the reason I am still immersed in the program is the same, the impact to the patient. 340B has a broad reach of direct & indirect financial patient benefits, increased access to those non-profit health care organizations providing care to those patients and enhancing the clinical services that pharmacies and others can provide those patients. I know that the work that everyone in the 340B space is doing is truly making a difference.

Q: What do you feel is your most significant contribution to the 340B world or to a 340B customer/client?

My most significant contribution to the 340B world is putting covered entities’ feedback first and not in a boxed solution. The ecosystem is ever changing, getting crowded and the needs of covered entities vary greatly. Listening to our client’s specific challenges and creating solutions that best fit both their needs and their patients is a critically important.  We have an amazing, client-focused team culture that results in highly successful partnerships with 340B providers.

Q: What advice do you have for a young professional who has recently launched a career in the 340B space?

Don’t underestimate the phenomenal talent of the professionals working in the 340B space. We are a mission driven community that is eager to help others.  Find, foster and grow relationships in the field with individuals with various perspectives on the program.

Lean into the obstacles that the 340B program faces as a way for you to shape the future. Ignoring the current pressures or trying to operate as if they will just go away one day will be counterproductive. In my opinion, the future and growth of the 340B program will come from innovation and evolution.

 

For questions, William can be reached at william.riley@alliancerxwp.com.

+ posts

Read more 340B Expert Tips

« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report